{"id":245608,"date":"2026-10-18T17:02:34","date_gmt":"2026-10-18T22:02:34","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/10\/resetting-the-eyes-cellular-clock-first-human-trial-results"},"modified":"2026-10-18T17:02:34","modified_gmt":"2026-10-18T22:02:34","slug":"resetting-the-eyes-cellular-clock-first-human-trial-results","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/10\/resetting-the-eyes-cellular-clock-first-human-trial-results","title":{"rendered":"Resetting the Eye\u2019s Cellular Clock: First Human Trial Results"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/90X3rZxYBWU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>The first safety test is done, and it is good.<\/p>\n<hr>\n<p>Life Biosciences has released the first human Phase 1 clinical trial safety data for ER-100, an AAV2 gene therapy testing partial epigenetic reprogramming in patients with open-angle glaucoma. In this video, we analyze the 56-day safety profile, early visual field perimetry results, and how inducible OSK transcription factors aim to restore optic nerve function.<\/p>\n<p>\ud83e\uddec SUPPORT THE CHANNEL &amp; LONGEVITY PARTNERS<br \/> \ud83d\udc49 Seeking Health (10% off: Richard10) <a href=\"https:\/\/crrnt.app\/SEEK\/polxleer\">https:\/\/crrnt.app\/SEEK\/polxleer<\/a> \u2014 PQQ, <a href=\"https:\/\/crrnt.app\/SEEK\/pPlZ42Wa\">https:\/\/crrnt.app\/SEEK\/pPlZ42Wa<\/a> \u2014 CoQ10<br \/> Renue By Science (10% off: MHS) <a href=\"https:\/\/tinyurl.com\/bdew4bfs\">https:\/\/tinyurl.com\/bdew4bfs<\/a> \u2014 NMN Powder \u2022 <a href=\"https:\/\/tinyurl.com\/4eu68vkb\">https:\/\/tinyurl.com\/4eu68vkb<\/a> \u2014 Lipo CoQ10.<\/p>\n<p>Stemregen (15% off: MODERN) US only <a href=\"https:\/\/tinyurl.com\/45z968yr\">https:\/\/tinyurl.com\/45z968yr<\/a>.<br \/> AX3 Life (20% off: MODERN20) <a href=\"https:\/\/ax3.life\/MODERN20\">https:\/\/ax3.life\/MODERN20<\/a> \u2014 Astaxanthin.<br \/> n1o1 (10% off: Modern) <a href=\"https:\/\/tidd.ly\/3IczGRW\">https:\/\/tidd.ly\/3IczGRW<\/a> \u2014 Nitric Oxide Lozenges.<br \/> Qualia (15% off: MODERN) Creatine+ <a href=\"https:\/\/tinyurl.com\/mr3z35jd\">https:\/\/tinyurl.com\/mr3z35jd<\/a> \u2022 Senolytic <a href=\"https:\/\/bit.ly\/4jlaibe\">https:\/\/bit.ly\/4jlaibe<\/a>.<br \/> Wellness Extract (10% off: MODERNWE) <a href=\"http:\/\/wellnessextract.com\/RICHARDWE\">http:\/\/wellnessextract.com\/RICHARDWE<\/a> \u2014 Geranylgeraniol \u2022 Vit E<br \/> Qitone (10% off: HEALTH10) <a href=\"https:\/\/tidd.ly\/4jGklry\">https:\/\/tidd.ly\/4jGklry<\/a> Qitone Esters Powder.<\/p>\n<p>\ud83d\udcda Chapters.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2026\/10\/resetting-the-eyes-cellular-clock-first-human-trial-results\">Continue reading \u201cResetting the Eye\u2019s Cellular Clock: First Human Trial Results\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first safety test is done, and it is good. Life Biosciences has released the first human Phase 1 clinical trial safety data for ER-100, an AAV2 gene therapy testing partial epigenetic reprogramming in patients with open-angle glaucoma. In this video, we analyze the 56-day safety profile, early visual field perimetry results, and how inducible [\u2026]<\/p>\n","protected":false},"author":388,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,269],"tags":[],"class_list":["post-245608","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/245608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/388"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=245608"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/245608\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=245608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=245608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=245608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}